Skip to main content
. 2019 Dec 18;14(12):e0225540. doi: 10.1371/journal.pone.0225540

Table 2. Baseline outcomes for all participants by intervention and control group.

Variable (range) ^ Intervention Baseline (N = 76) Control Baseline
(N = 79)
Mean (SD) Mean (SD) P-value
Average pain (0–10) 7 (1.9) 7 (1.9) 0.97
BPI Interference (0–10) 7 (2.2) 6 (2.3) 0.47
BPI Severity (0–10) 7 (1.9) 7 (1.8) 0.95
PHQ (0–27) 13 (5.6) 11 (5.3) 0.11
Pain Self-Efficacy (0–60) 30 (15.4) 32 (13.5) 0.47
Patient Activation Measure (0–100) 60 (15.6) 56 (11.8) 0.05*
SF-12 Physical Composite Score (0–100) 33 (10.3) 35 (10.6) 0.12
SF-12 Mental Composite Score (0–100) 35 (9.5) 36 (10.3) 0.62
Current Opioid Misuse Measure (0–64) 11 (5.9) 9 (5.8) 0.05*
N % N % P-value
Pain medication past 7 days 67 88 65 82 0.30
Emergency Department Use 15 21 11 14 0.28

*Significant differences between the intervention and control group for PAM (p = 0.0513), COMM (p = 0.0495) at a significant level of 0.1, so they were adjusted for in all subsequent models.

^Continuous variables are summarized with mean (standard deviation)